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A-to-I editing in human miRNAs 
is enriched in seed sequence, 
influenced by sequence contexts 
and significantly hypoedited in 
glioblastoma multiforme
Deepanjan Paul1,2, Ashis Narayan Sinha1, Arjun Ray  1,2, Megha Lal1,2, Subhashree Nayak3, 
Anchal Sharma1,2, Bharati Mehani1,2, Debasish Mukherjee  1, Saurabh V. Laddha1, Ashish 
Suri4, Chitra Sarkar3 & Arijit Mukhopadhyay1,2,5
Editing in microRNAs, particularly in seed can significantly alter the choice of their target genes. We 
show that out of 13 different human tissues, different regions of brain showed higher adenosine to 
inosine (A-to-I) editing in mature miRNAs. These events were enriched in seed sequence (73.33%), 
which was not observed for cytosine to uracil (17.86%) editing. More than half of the edited miRNAs 
showed increased stability, 72.7% of which had ΔΔG values less than −6.0 Kcal/mole and for all of 
them the edited adenosines mis-paired with cytosines on the pre-miRNA structure. A seed-editing 
event in hsa-miR-411 (with A – C mismatch) lead to increased expression of the mature form compared 
to the unedited version in cell culture experiments. Further, small RNA sequencing of GBM patients 
identified significant miRNA hypoediting which correlated with downregulation of ADAR2 both in 
metadata and qRT-PCR based validation. Twenty-two significant (11 novel) A-to-I hypoediting events 
were identified in GBM samples. This study highlights the importance of specific sequence and structural 
requirements of pre-miRNA for editing along with a suggestive crucial role for ADAR2. Enrichment of 
A-to-I editing in seed sequence highlights this as an important layer for genomic regulation in health 
and disease, especially in human brain.
RNA molecules undergo multiple post-transcriptional modifications1 for performing diverse functions. Various 
efforts have been made for identification2, 3 and understanding the significance of these modifications4, 5. RNA 
editing – the most well studied modification - changes the information encoded by the genome and adds com-
plexity to the gene regulatory networks6–8. The predominant editing event, adenosine-to-inosine (A-to-I) is medi-
ated by ADAR (Adenosine deaminase acting on RNA) family members which acts on double-stranded RNA 
(dsRNA) with or without a perfect complementarity9. With the advent of next generation sequencing multiple 
groups have devised experimental10, 11 as well as computational12, 13 approaches to identify genome-wide A-to-I 
editing events in RNA. For protein-coding transcripts A-to-I editing is essential for normal development14, 15 and 
is enriched in the brain16. A-to-I modification happens more promiscuously within perfect dsRNA substrates, 
deaminating up to 50% of the adenosine residues17 whereas internal mismatches and bulges in dsRNA substrates 
is associated with ADAR selectivity18.
Another form of canonical RNA editing event involves cytosine to uracil (C-to-U) deamination15 mediated by 
APOBEC1 (apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 1). APOBEC1 mediated editing 
events provide tissue specificity and diversity for ApoB mRNAs19 but deregulation of APOBEC1 can also bring 
about devastating phenotype like cancer20.
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MicroRNAs (miRNAs) are ~22 nucleotide long, non-coding RNA which usually down regulate gene expres-
sion by binding to the 3′-untranslated region (3′-UTR) of mRNAs21. Bases 2–8 (seed region) from the 5′-end of 
the mature miRNA are critical determinants of target complementarity22. Premature forms of a miRNA, being a 
dsRNA molecule, can undergo A-to-I editing at different stages of biogenesis affecting it’s maturation and expres-
sion9, 23. A recent paper has shown that ADAR1 can bind to miRNAs in its primary, precursor and mature forms, 
where binding to the primary miRNA was found to be the highest24. A-to-I editing in miRNAs can affect its 
cleavage in the nucleus25 or cytoplasm26 and might also result in altered target genes. MiRNA editing has been 
shown to be important in tissue specific regulation in normal brain27. A recent study has also shown that A-to-I 
editing in miRNA increases during development, by analysing different developmental stages of mouse brain28.
There is a considerable body of literature for A-to-I editing events in miRNAs27, 29, 30. Recently, studies have 
also started reporting importance of C-to-U editing in miRNAs31, 32. However, for both these canonical miRNA 
editing types, the tissue specific spectrum in normal human tissues remains to be seen. In addition, currently 
there is no consensus on effect of editing at pri/pre level on processing and expression of mature miRNAs. There 
are reports that indicate both enhanced33, 34 and reduced25, 26, 35 processing and expression upon editing.
In this study we have performed a massively parallel sequencing based large-scale analysis for both A-to-I and 
C-to-U editing on human miRNAs across 13 different tissues. We explored the positional bias of these events and 
the role of editing in pri-miRNA on mature miRNA expression. Further, editing in different parts of the brain 
from same individuals were analyzed to look for intra-individual variability and compared with the scenario in 
brain from patients of glioblastoma multiforme.
Results
A-to-I editing in miRNAs are enriched in seed sequence in diverse human tissues. We have ana-
lysed >1 billion sequences from 50 small RNA sequencing experiments representing 13 diverse healthy human 
tissues (Supplemental Table S1) and identified 60 and 56 non-redundant A-to-I and C-to-U editing events, 
respectively (Supplemental Table S2). A-to-I editing levels within mature miRNAs were found to be the highest 
in prefrontal cortex followed by total RNA from brain (Fig. 1A) whereas for C-to-U, liver revealed higher editing 
(Supplemental Figure S1). Prefrontal cortex harbored 30 non-redundant A-to-I sites (4.63% of the total expressed 
miRNAs; average of six independent experiments), 11 of which were found in all six samples (Supplemental 
Figure S2A). Total RNA from brain had 24 A-to-I sites (3.47% of the total expressed miRNAs; average of three 
independent experiments) out of which eight sites were found in all three samples (Supplemental Figure S2B). 
Amongst other tissues editing was found to be higher in lung (3.16%; average of six independent experiments; 
Fig. 1) with 23 non-redundant sites, eight of which were shared in all six samples (Supplemental Figure S2C). 
Such consistent editing events across multiple samples for other tissues were also found. A detailed list of all 
A-to-I and C-to-U editing events in all tissues is provided in Supplemental Table S2.
Figure 1. Distribution of A-to-I editing in different healthy human tissues. (A) A-to-I editing in mature 
miRNAs is the highest in Prefrontal cortex (two-tailed t-test; p = 0.003 with respect to lung samples). 
Percentage A-to-I editing was calculated by dividing the number of edited miRNAs by the total number of 
miRNAs expressed with a read count greater than equal to 10. The numbers above the bars represent the 
number of different individuals analysed. (B) C14 miRNA cluster show enriched A-to-I editing. The fraction 
of edited miRNAs from C14 was significantly higher compared to the miRnome average in all tissues analyzed 
(p < 0.008), the tissues have been arranged according to descending order of miRnome-wide editing.
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Thirteen out of 60 non-redundant A-to-I editing events (21.66%) were located on chromosome 14. Ten out 
of these 13 were in miRNAs belonging to the large miR-379/miR-656 cluster alone (henceforth C14MC). For all 
tissues analysed the fraction of edited miRNAs from C14MC was significantly higher compared to the random 
chance namely the miRnome average (p < 0.008; Fig. 1B).
We focused on editing events occurring within the seed sequence of mature miRNAs and found 73.33% 
(44/60) such sites, whereas such a bias was not observed for C-to-U editing (Fig. 2A; p = 6.66 × 10−9). 
Interestingly, 43% (19/44) of the A-to-I events were located in 4th and 5th positions of the seed without any specific 
bias for adenosine in those positions (Fig. 2B and Supplemental Figure S3).
Neuron rich frontal cortex has more A-to-I editing events than corpus callosum of the same 
individuals. We have performed small RNA sequencing using massively parallel sequencing methods in 
paired samples of frontal cortex (FC) and corpus callosum (CC) from six individuals. We had exome sequence 
(DNA) data available for four of these pairs. The exome data was used to rule out the possibility that the A-to-I 
editing sites were due to variations at the DNA level of the specific individuals. Out of all sites, 75% (33/44) and 
70.58% (24/34) were captured by the exome data, in FC and CC, respectively (Supplemental Figure S4A and B). 
Two observed A > G variations were found independently in FC and CC DNA and hence were excluded from the 
editing dataset. Over-laying the sites with dbSNP (build 142) identified two SNPs, one in FC (rs515924, A-to-G) 
and the other (rs554506562) both in FC and CC, which were also excluded. After filtering out these variations 
at the DNA level, the extent of editing was significantly higher in FC than CC (p = 0.015; Fig. 3A) as well as for 
all other tissues (p = 0.02 with respect to lung). Our analysis revealed a total of 157 and 122 mature miRNA 
A-to-I sites in FC and CC, respectively (41 and 32 non-redundant sites in FC and CC, respectively; Supplemental 
Table S2). As observed for other tissues, in FC and CC also we found an enrichment of editing events within the 
seed region (70.73% in FC and 75% for CC, Supplemental Table S2). More than one-third of them were present 
in all six samples for FC and CC. The novel A-to-I miRNA editing events detected in our study is provided in 
Supplemental Table S3. We did not find significant difference (p = 0.54) in the levels of C-to-U editing between 
FC and CC samples (Supplemental Figure S4C and D and Supplemental Figure S5).
An event in let-7e showed tissue specificity as well as intra-individual differences in miRNA editing. Hsa-let-7e 
was expressed in all tissues, while an editing event in its seed sequence was exclusively found in FC (4 out of 6, up 
to 4.76% edited, Supplemental Table S2) but not in the corpus callosum of the same individuals which has been 
validated using targeted SnaPshot experiments (Supplemental Figure S6). The edited form potentially targets 
three genes whereas the unedited form has five targets with none in common (Supplemental Table S4). Apart 
from these there were five other editing events, which were specific to FC samples and one event specific to CC 
samples (Supplemental Table S4).
Since ADAR family members are known to mediate the A-to-I editing events, we checked the expression 
of ADAR1 and ADAR2 in FC and CC by quantitative PCR. Interestingly, for five sample-pairs tested, ADAR2 
expression levels were significantly higher in FC than CC (p = 0.008; Fig. 3B) in line with increased editing levels 
in FC (Fig. 3A). Such a significant expression difference was not observed for ADAR1 (p = 0.63, Fig. 3B).
Figure 2. A-to-I editing in mature miRNAs is enriched in seed sequence. (A) 73.33% (44/60) of the A-to-I 
editing events was found to be localized in the seed sequence of mature miRNAs whereas for C-to-U only 
17.86% (10/56) were in the seed sequence. This enrichment is significantly (two-tailed proportional test, 
p = 6.66 × 10−9) higher for A-to-I compared to C-to-U. (B) Primary y-axis (bars) shows the number of 
editing events in the seed, the secondary y-axis (line) shows the percentage of adenine in seed sequences of all 
human mature miRNAs (miRBase20) and the x-axis shows the position within the seed (where position 1–7 
corresponds to position 2–8 from the 5′-end of mature miRNAs). 19 out of 44 seed editing was located in the 
4th (nine events) and 5th (ten events) positions of the seed (marked by black arrow) without a bias for adenine at 
that position in human mature miRNAs.
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A-to-I (and not C-to-U) edited miRNAs are predictably more stable than their unedited 
forms. Using RNA secondary structure analysis we observed that 55% of the edited sites in pre-miRNAs (33/60; 
Supplemental Table S5A) show an increased stability whereas 16.67% (10/60) show no change in free energy and 
the rest show a minor decrease in stability (ΔΔG is 0.1 to 0.9 Kcal/mole). 72.7% (24/33) of the edited sites in 
pre-miRNAs that gain on stability has ΔΔG values less than −6.0 Kcal/mole (Fig. 4A). Only six out of 56 C-to-U 
edited events (10.71% compared to 55% for A-to-I) were predicted to have increased stability (ΔΔG < 0 kcal/
mole) upon editing (Supplementary Figure S7 and Supplementary Table S5B). As ADAR specifically edits dou-
ble stranded RNA (dsRNA) substrates, we checked the sequence context of the pre-miRNA hairpins. For all the 
miRNAs that gained stability upon editing (ΔΔG < −6.0 Kcal/mole) the edited adenosines had mis-paired cyto-
sines on the pre-miRNA hairpin structure (Fig. 4B and Supplemental Table S5A). This was not observed for the 
edited sites that did not provide a stability advantage based on free energy change (Supplemental Table S5A). To 
validate the altered minimum free energy levels upon editing, we randomly selected 18 miRNAs to check in the 
three-dimensional structure. Nine out of the 10 candidates that gained in stability in 2D analysis showed the same 
trend in three-dimensional analysis (Supplemental Table S5A). All these miRNAs had an A-C mismatch in the 
pre-miRNA hairpin structure pointing towards the importance of this mismatch in conferring stability upon editing.
Figure 5 shows the structural features of unedited and edited forms of miR-1301 as a representative example 
in both two and three dimensional space. The edited species makes 4 hydrogen bonds with guanine while the 
unedited species has only 1 with adenine (the total hydrogen bonds was 113 and 122, in unedited and edited 
structures, respectively). The decrease in Gibb’s free energy in 2D is reflected by more compact and ordered struc-
ture in 3D (Fig. 5C) with corresponding change in its entropy profile (Fig. 5B).
ADAR2 downregulation and miRNA hypoediting in Glioblastoma Multiforme. In order to check 
the expression of ADARs in a disease scenario, we have analyzed data available in the TCGA server for 593 GBM 
samples and controls. The expression of ADAR2 was significantly downregulated (after bonferroni correction, 
p = 0.004; Supplemental Figure S8) in GBM. In line with the results described above such significant downregu-
lation was not observed for ADAR1 in the TCGA data (p = 0.2; Supplemental Figure S8).
We observed significant hypoediting of mature miRNAs in a set of five GBM samples that we sequenced 
compared to the six FC and six CC samples used as controls (2.06% in GBM, 4.43% in FC and 3.38% in control; 
p = 0.009 and p = 0.004, respectively; Fig. 6A). These GBM samples also showed significant downregulation for 
ADAR2 (p = 0.002 and p = 0.009; Fig. 6B) which most likely have resulted in the observed hypoediting. When 
checked for individual miRNAs in GBM samples that were edited in FC and CC (total 29 non-redundant events 
in at least 3 FC and CC samples), 22 (75.86%) showed significant hypoediting (Wilcoxon-two-tailed, p < 0.05) 
or no editing in GBM. Eleven out of these 22 events were novel miRNA hypoediting events in GBM (Table 1). 
The hypoediting for three miRNAs was also confirmed by SnaPshot experiments (Fig. 7A and Supplemental 
Figure S9). Sixteen out of 22 events were within the seed sequence and would result in drastic redirection of 
targets with the maximum target overlap before and after editing being only 7.53% (Table 1). For eight of these 
hypoedited miRNAs the editing level was below the level of detection in all GBM samples and amongst others we 
observed up to 5-fold reduction of the level of editing in GBM (e.g. for hsa-miR-411, Table 1).
Figure 3. Neuron rich frontal cortex (FC) showed higher A-to-I editing in mature miRNAs than the 
corresponding corpus callosum (CC) of the same individuals. (A) FC showed higher A-to-I editing than CC 
of the same individuals (two-tailed t-test; p = 0.015). (B) Real-time PCR was done and delta Ct was plotted, 
ADAR2 (and not ADAR1, two-tailed t-test; p = 0.63) showed significant upregulation in FC compared to CC 
samples (two-tailed t-test; p = 0.008). B2M was used to normalize expression in all samples.
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We investigated differentially expressed miRNAs in GBM compared to FC samples from the miRnome-wide 
data and identified 263 and 292 up- and downregulated miRNAs, respectively (303 and 268 up- and down-
regulated miRNAs when compared with CC, Supplemental Table S6A and B). When checked for the altered 
expression of the hypoedited miRNAs, we found 45.45% (10/22) to be downregulated in GBM (Table 1 and 
Supplemental Table S6A). Downregulation of four miRNAs found to be hypoedited and downregulated in GBM 
compared to both FC and CC samples were further validated by qRT-PCR (Fig. 7B and Supplemental Table S7). 
Seven pre-miRNAs out of these 10 were predicted to have increased structural stability upon editing (ΔΔG val-
ues < −6.0 Kcal/mole) and all of them had an A-C mismatch in the pre-miRNA hairpin structure (Supplemental 
Table S5A). To test the hypothesis that such a gain in stability can positively influence pri-miRNA processing – we 
have selected miR-411 as a representative miRNA, based on its editing across all tissues studied, an A-C mismatch 
at the editing site, seed sequence editing and its being one of the miRNAs showing downregulation and hypoed-
iting in GBM. In cell based assays it was found that the expression level of mature miR-411 (edited) was 3.5 fold 
higher than the un-edited version (Fig. 8). The results were in agreement when compared with the empty vector 
construct (Supplemental Figure S10).
We found miRnome-wide hypoediting also for C-to-U editing events in GBM compared to FC and CC sam-
ples (Supplemental Figure S11) and identified 10 novel hypoediting events (Supplemental Table S8) in GBM.
Discussion
A-to-I editing in miRNA, or its absence, has been shown to have major consequences for cellular outcomes27, 
36. We embarked on a large-scale analysis of A-to-I editing in mature miRNAs from small RNA sequencing data 
across 13 different human tissues. Overall we observed that adenosines flanked by a uracil (5′) and guanine (3′) 
were more prone to get edited (Supplemental Figure S12), which is in agreement with recent reports29, 34, 37, 38. 
MiRNAs where the edited adenosine was part of the UAG motif showed significantly higher levels of editing than 
those, which did not have this sequence context (average values 10.21% vs. 3.05%, one-tailed t-test, p = 0.02). 
Notably, in almost all possible motifs where the adenine residue was preceded by a guanine – it was not edited 
(Supplemental Figure S12D).
The ADAR mediated deamination requires the substrate to be double stranded9. We analysed the base-pairing 
context of the edited adenosines in the hair-pin structure of the pre-miRNA – which revealed a bias for a mis-pair 
with cytosine (Fig. 4B). An editing at these sites will create a better base-pairing of cytosine with guanine (ino-
sine), predictably enhancing the stability of the dsRNA – also supported by other studies29, 39. This enhanced 
stability was observed at the level of both 2D and 3D structures of the precursor miRNAs (Figs 4A and 5). Overall, 
the precursors that gained maximum stability upon editing (ΔΔG ≤ −6.0 Kcal/mole) showed higher levels of 
editing (average editing 6.94%) compared to those, which did not have any gain in free energy (ΔΔG ≥ 0, average 
Figure 4. A-to-I edited miRNAs show predicted increased stability than their unedited forms. (A) The 
minimum free energy (MFE) for edited (“G” containing) and unedited (“A” containing) pre-miRNA was 
obtained using RNA fold. ΔΔG was calculated by subtracting MFE of unedited miRNA from edited miRNA. 
Negative value of ΔΔG means more stable edited forms. 55% (33/60) sites showed an increase in stability 
(ΔΔG < zero), 24 out of the 33 sites showed a value less than −6 Kcal/mole. (B) The motif for sequence 
preference in the pre-miRNA fold-back structure is analysed. For all the miRNAs that gained stability upon 
editing (ΔΔG < −6.0 Kcal/mole) the edited adenosines were found to have mis-paired cytosines on the pre-
miRNA hairpin structure.
www.nature.com/scientificreports/
6Scientific RepoRts | 7: 2466  | DOI:10.1038/s41598-017-02397-6
Figure 5. The two- and three-dimensional analysis for a representative pre-miRNA (mir-1301) unedited and 
edited sequence. (A) The minimum free energy secondary structures and its sequences, colored according 
to the base-pairing probability. The structure was predicted using RNAFold which uses a loop-based energy 
model and the dynamic programming algorithm. (B) The corresponding positional entropy for each position. 
(C) The lowest free energy three-dimensional structure was built using mcfold followed by mcsym where the 
RNAFold’s secondary structure information was given as structural constrain for unpaired nucleotides. The 5p 
arm is colored as blue while the 3p arm is colored green, with the edited nucleotide colored as pink. ‘I’ represent 
the unedited form while ‘II’ represents the edited form. The arrows mark the site of editing. The minimum free 
energy change at the two- and three dimensional levels for the unedited and edited pre-mirna-1301 is provided 
in Supplemental Table S5A.
Figure 6. MiRnome wide hypo-editing and ADAR2 downregulation in glioblastoma multiforme. (A) Small 
RNA sequencing revealed miRnome-wide significant (two-tailed Wilcoxon test) hypoediting in GBM compared 
to FC (p = 0.009) and CC (p = 0.004) samples. (B) Real time PCR validation of ADAR2 in GBM samples 
compared to FC and CC samples. Y-axis shows ΔCt values of ADAR2 in five FC, five CC and five GBM samples 
and B2M expression was used for normalization. ADAR2 is significantly (two-tailed t-test) downregulated in 
GBM compared to FC (p = 0.002) and CC (p = 0.009) samples.
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editing 2.55%, one-tailed t-test; p = 0.03). We have also shown for miR-411 in cell based assays that the edited 
form was significantly more expressed than the unedited version (Fig. 8 and Supplemental Figure S10). Recently, 
similar observations have been made where edited miR-497* (also with A-C mismatch) showed increased pro-
cessing by Drosha and was found to be the most downregulated in ADAR2 deficient mice33. It is reported that 
for a pre-miRNA secondary structure a perfect hairpin might be a barrier for efficient maturation process and/
or a promiscuous editing17, 40. However, our study along with others33 indicates that a local mismatch (A-C), 
which can be removed through editing (I/G-to-C), can actually lead to a better processing for specific miRNAs. 
The functional link between ADAR group of enzymes and editing vis-à-vis processing of miRNA needs to be 
studied in greater depth. A recent paper has shown ADAR2 overexpression alters expression of large number 
of miRNAs35. The miRNAs showing reduced expression were mostly onco-miRs, where an editing event can be 
protective by negatively affecting processing to mature miRNAs35. Similarly, it will be important to identify tumor 
suppressor miRNAs where an editing event can lead to a natural protection by positively affecting the miRNA 
maturation. Interestingly, in our study, miR-411 is a potential tumor suppressor miRNA41 where an editing event 
leads to increased processing – indicating such possibilities in a larger scale.
ADAR family members, especially ADAR1 and ADAR2 have been shown to have both overlapping and 
unique editing targets for mRNAs42 and miRNAs27, 42, 43. It has been recently shown that ADAR2 expression cor-
related more with the mRNA editing levels in cerebellum and prefrontal cortex than it did with ADAR144 – which 
is also supported in case of miRNA by others29, 33 and by this study. We observed significantly higher expression 
of ADAR2 in FC compared to the corresponding CC samples (not observed for ADAR1), hinting that one of the 
many possible reasons for higher editing in FC can be due to higher expression of ADAR2. It remains to be seen 
whether functional requirement of higher editing levels in post-mitotic cells of the adult brain (e.g. neurons) 
induces increased expression of the editing enzyme.
We have studied glioblastoma multiforme (GBM) as a representative disease of the brain to understand the 
possible dysregulation of miRNA editing in disease. Small RNA sequencing of five GBM samples revealed overall 
hypoediting of miRNA compared to six FC and six CC samples and identified 22 (11 novel) hypoediting events in 
GBM. Interestingly, eight of these 22 hypoedited miRNAs belonged to the miR-379/miR-656 cluster. It has been 
suggested that miRNAs in C14MC results from a large polycistron45 and it possibly functions as a single tumor 
suppressor gene41. Whether an increased editing adds to this cluster’s functional diversity will be revealed by 
further studies. We also observed downregulation of ADAR2 in GBM samples both in meta-data (TCGA dataset, 
Supplemental Figure S8) and qRT-PCR based validation (Fig. 7B) in our samples.
miRNAs
aPresence 
in samples bMedian editing (in %) Seed editing event
Position in 
precursor
Target Prediction
cOverlap (%)Before/After editing
hsa-mir-598-3p 6/5/0 0.49/0.34/0 Yes 62 11/9 0 (0)
hsa-mir-376a-1-5p 6/6/0 11.24/8.43/0 Yes 9 131/166 4 (3.05)
hsa-mir-337-3p* 4/1/0 4.21/−/0 Yes 66 146/197 11 (7.53)
hsa-mir-376c-3p 6/5/2 3.72/1.9/− Yes 48 156/192 11 (7.05)
hsa-mir-1301-3p#,* 6/6/2 7.59/3.94/− Yes 52 230/7 2 (0.87)
hsa-mir-421 6/6/3 1.40/0.61/0.57 Yes 54 271/4 1 (0.37)
hsa-mir-99b-3p* 6/6/2 3.61/1.65/− Yes 47 33/21 0 (0)
hsa-mir-641-5p 6/6/3 5.62/7.08/3.35 Yes 18 355/128 11 (3.1)
hsa-let-7e-3p* 4/0/0 2.09/0/0 Yes 57 5/3 0 (0)
hsa-mir-1251-5p#,* 4/4/0 11.98/11.87/0 Yes 10 58/305 4 (6.9)
hsa-mir-381-3p# 6/6/5 6.87/7.15/3.07 Yes 52 638/302 48 (7.52)
hsa-mir-411-5p 6/6/5 27.57/30.85/5.71 Yes 20 64/58 0 (0)
hsa-mir-130a-3p 5/5/0 0.76/0.97/0 Yes 56 724/172 27 (3.73)
hsa-mir-151a-3p 6/6/3 2.87/1.26/0.48 Yes 49 76/77 3 (3.95)
hsa-let-7d-3p 6/4/0 0.70/0.31/0 Yes 66 9/1 0 (0)
hsa-mir-27b-3p* 5/0/0 0.25/0/0 Yes 64 921/8 2 (0.22)
hsa-mir-301b-3p* 5/2/1 1.24/−/− No 63 NA NA
hsa-mir-340-3p* 4/0/0 1.19/0/0 No 70 NA NA
hsa-mir-377-3p* 4/3/0 8.10/4.6/0 No 54 NA NA
hsa-mir-539-5p* 6/6/0 2.23/1.62/0 No 18 NA NA
hsa-mir-889-3p* 5/5/0 0.62/0.41/0 No 62 NA NA
hsa-mir-99a-5p 6/6/4 3.40/1.44/0.30 No 13 NA NA
Table 1. A-to-I hypoedited miRNAs in Glioblastoma Multiforme (GBM). 22 miRNAs were found to be 
significantly hypoedited in GBM (wilcoxon-two-tailed, p < 0.05). aPresence in samples (FC/CC/GBM). bMedian 
editing (FC/CC/GBM). cPercentage overlap was calculated by overlapped targets/targets before editing. NA, 
not applicable because they were not seed editing events. “−”Indicates miRNAs where median value could 
not be calculated. The asterisk (*) represents 11 novel miRNAs found to be hypoedited in GBM in this study. 
“#”Indicates events validated by SNPShot (data in Fig. 7A and Supplemental Figure S9).
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Through this study we have been able to show that in both healthy and diseased state, miRNA editing is 
an important layer of information with specific sequence and structural preferences – especially in the human 
brain. Such varied layers of regulatory parameters in the biological systems makes them inherently complex and 
intricately interconnected – achieving remarkable plasticity that is required to dynamically evolve in situations 
hitherto unknown.
Materials and Methods
Samples. Portions of Frontal cortex (Grey matter) and Corpus Callosum (White matter) were obtained 
from post-mortem samples of road accident victims. The samples were obtained from NIMHANS Brain Bank, 
Bangalore, India. GBM samples were obtained from AIIMS, New Delhi, India. The samples were collected 
according to the Helsinki Declaration and the ethical review board of All India Institute of Medical Sciences, 
Delhi, India approved the project. Sample collection, characterization and storage were done as described previ-
ously41. Diagnosis and grading of tumor samples were done as per 2007 WHO classification.
The details of the samples used in the study are provided in Supplemental Table S1.
RNA isolation, library preparation and sequencing. Total RNA was isolated from Frontal Cortex, 
Corpus Callosum and GBM samples using miRvana miRNA isolation kit (Ambion, USA) as per the manufac-
turer’s instructions. Libraries were prepared using Illumina’s TruSeq Small RNA Sample prep Kit following the 
manufacture’s protocol. Cluster generation and sequencing was done on Illumina HiSeq2000 using standard 
Illumina sequencing workflow with the multiplexing option. Two samples were loaded in one lane and 50 bases 
single-end sequencing was done. The in-house small RNA sequencing data is deposited at the sequence read 
archive (SRA ID: SRP063390).
Figure 7. Validation of hypoediting and downregulation of mirna in GBM. (A) The X- and Y-axes represents 
the relative size of the SnaPshot product and relative fluorescence unit (RFU) respectively. One representative 
example of hypoedited miRNA (mir-1301) in GBM is shown. The editing event observed in normal brain RNA 
(I) is absent in the GBM tumor RNA (II) and in the normal genomic DNA (III). The SnaPshot specific primer 
was chosen from the negative strand, hence A to I (G) editing is depicted as T and C peaks. (B) Real time PCR 
validation of downregulation for hypoedited miRNAs in GBM samples compared to CC samples. Y-axis shows 
ΔCt values of miRNAs in five CC and five GBM samples and U6 snRNA expression was used for normalization. 
Statistical significance of downregulation was determined by one-tailed t-test. The delta Ct values for these four 
miRNAs are provided in Supplemental Table S7.
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Data analysis. Data analysis was done using the published pipeline29 with the default parameters. Briefly, 
the 3′ adapters were removed from the sequencing reads. Reads shorter than 15 bases and longer than 28 bases 
were discarded. The trimmed reads were aligned against the genome using Bowtie 0.12.7 allowing 1 mismatch. 
Reads were mapped to pre-miRNA sequences (from miRBase 20) and binomial statistics was used to filter-out 
sequencing errors. Only significant (p-value < 0.05, post Bonferroni correction) modifications were considered. 
miRNAs with a minimum read-count 10 was considered. The software and detail description is available at <tau.
ac.il/~elieis/miR_editing>.
dbSNP build 142 and exome sequencing data was used to filter out variations at the DNA level.
Percentage of A-to-I editing was calculated in the following way:
Percentage A-to-I editing = (Number of edited miRNAs/Total miRNAs expressed with greater than equal to 
10 read counts) * 100. The same was followed for C-to-U editing.
Publicly available small RNA sequencing data. The detailed list of the public domain sequencing data 
is provided in Supplemental Table S1. The same pipeline was used for both in-house and publicly available dataset 
for calling miRNA editing events.
DNA isolation and Exome Sequencing. DNA was isolated from brain tissues using Omniprep Genomic 
DNA isolation kit (G-Biosciences, USA) as per manufacturer’s protocol. Exome capture was done using Illumina 
TruSeq Exome capture kit. 100 base pair paired end sequencing was done using Illumina HiSeq 2000 (Ilumina, 
USA). The exome sequence data is publicly available at the sequence read archive (SRA ID: SRP045655).
Exome sequencing data analysis. Raw data was checked for per base quality score and reads having 
80% bases with phred quality score 30 and greater were carried forward for downstream analysis and rest were 
discarded.
Alignment. Reads were aligned to the reference genome (hg19) using BWA (version 0.6.1)46 allowing for 2 mis-
matches. More than 98% percent of the data was aligned to reference for each sample. Data was also checked for 
PCR duplicates and the same were removed.
Variation Calling. Genome Analysis Toolkit version 1.547 along with Samtools (version 0.1.18)48 was used to call 
variations from all the paired samples (CC vs. FC). Variants with >90% strand bias were removed, minimum base 
quality score was kept at 20 and minimum mapping quality of a read was kept at 40.
Figure 8. Increased expression of mature edited form of hsa-miR-411. (A) The figure shows the predicted 
secondary structures for the unedited (I) and edited (II) versions of pre-mir-411 using RNAfold Webserver. 
The arrow shows the position of editing found experimentally in mature miR-411–5p. The edited version (A 
changed to G) was predicted to have a more stable structure (ΔΔG = −6.6 kcal/mol). (B) qRT-PCR data shows 
altered expression upon editing. A significant (two-tailed t-test, p = 0.001) increase in expression (3.5 fold, 
average of three replicates) was observed only for the mature form of miR-411. No significant (two-tailed t-test, 
p = 0.41) change was observed at the level of pri- and pre-mirna.
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Target prediction. The target prediction for unedited and edited miRNAs was done using TargetScanHuman 
5.2 Custom (http://www.targetscan.org/vert_50/seedmatch.html) with the 7-mer seed sequence from 2 to 8 
nucleotides as an input49.
Motif analysis. Ten bases up-stream and down-stream of the edited adenosine was taken for the motif anal-
ysis using WebLogo (http://weblogo.berkeley.edu/logo.cgi)50 and the frequency of bases at each position was cal-
culated. The motif analysis was done for all the 60 miRNAs found to be edited in our study.
To look for tri-nucleotide sequence enrichment within pre-miRNAs, 1872 human pre-miRNAs was down-
loaded from miRBase v20. Three bases sliding window was taken to analyse enriched tri-nucleotides within 
pre-miRNAs using an in-house perl program.
Two dimensional (2D) and three dimensional (3D) structural analyses. Minimum free energy 
(MFE; ΔG) for the unedited and edited miRNAs was predicted at the 2D and 3D level. For secondary structure 
analysis RNAfold WebServer (http://rna.tbi.univie.ac.at/cgi-bin/RNAfold.cgi)51 was used to calculate the par-
tition function and base pairing probability matrix in addition to the MFE structure. MFE is calculated using 
a loop-based energy model (using Turner model for Energy Parameters) and McCaskill’s algorithm52 for the 
secondary structures contributing towards the minimum free energy in the RNA by summing the contributing 
free energies from the loops at 37 °C. The unedited and the edited pre-miRNAs were given as inputs for ΔG pre-
diction. ΔΔG was calculated by subtracting ΔG of unedited from ΔG of edited pre-miRNAs.
For 3D structural analysis, 18 candidate miRNAs were chosen (Supplemental Table S5A) and the optimal 
secondary structure in dot-bracket notation (from RNAfold WebServer) was used as structural constrains in the 
MC-Fold | MC-Sym pipeline53. Structural constrains forces certain nucleotides to be either paired or unpaired 
and will restrict the conformational search space. The advantage of using a dual approach is that it shall use 
the best secondary model from the first method and feed it as a template to guide and further predict the new 
secondary structure using the mcfold algorithm. The final tertiary structure of the pre-miRNA was predicted 
using mc-fold mc-sym pipeline. The energy-minimized model was obtained using the method’s scoring function, 
which calculates the base pairing energy contribution by reducing the nucleotides into cyclic motifs ΔΔG of the 
tertiary structure was calculated in the same way as that of the secondary structure.
Expression analysis of ADAR1 and ADAR2. 1 micro-gram of RNA was converted into cDNA using 
High-Capacity cDNA Reverse transcription kit (Thermo Fischer Scientific) as per manufacturer’s protocol in a 
reaction volume of 20 μl. qRT-PCR (in duplicates) of ADAR1 and ADAR2 was done in five pairs of FC and CC 
samples. qRT-PCR was not performed in one pair due to limited amount of sample. The expression level of B2M 
was used for normalization. Statistical significance was calculated on the basis of two-tailed paired t-test.
We have downloaded the mRNA expression data of 593 GBM patients and 10 controls (Agilent G4502A 
array) from TCGA data portal and analyzed expression, which was lowess normalized data (level3). Differential 
expression of mRNA between patients and controls was determined using a non-parametric two-tailed wilcoxon 
test. A Bonferroni correction was done to find out the list of significant differentially expressed mRNAs (p < 0.05, 
post-correction). The significant (two-tailed paired t-test) down regulation of ADAR2 was validated in five GBM 
samples compared to five FC and five CC samples by qRT-PCR.
Differential miRNA editing and expression in GBM. Small RNA sequencing was done for five GBM 
samples. The status of miRNAs found to be edited in at least three FC and CC samples (29 non-redundant 
events) were compared with the GBM samples and differentially edited miRNAs were identified using two-tailed 
Wilcoxon test (p < 0.05).
DESeq2 package in R54 was used to identify differential expressed miRNAs in GBM compared to FC and CC 
samples. Two-step filtering was done to reduce false positives; an adjusted p-value (p < 0.1) cut-off followed by 
a fold change value of ±1.5 was used for further analysis. The data for DESeq2 (Supplemental Table S6A and B) 
represents the fold change in log2 scale (≥0.60 for upregulation and ≤−0.60 for downregulation).
Hypoedited and downregulated miRNAs in GBM. Hypoedited miRNAs were validated using SnaPshot 
reaction. Downregulation of miRNAs were validated using qRT-PCR. Briefly 0.4 micro-gram of RNA was con-
verted into cDNA using QuantiMir kit (System Biosciences, USA) as per manufacturer’s protocol in a reaction 
volume of 10 μl. qRT-PCR (in duplicates) of hypoedited miRNAs were done in five GBM and five CC samples. U6 
snRNA expression level was used for normalization.
Overexpression in HEK293T cell line. A genomic region encompassing mir-411 was cloned in a mod-
ified pRIP vector (673 base-pairs). Site-directed mutagenesis was performed using QuikChange Site-Directed 
Mutagenesis Kit (Agilent) following manufacturer’s protocol. The unedited and edited constructs were sepa-
rately transfected for overexpression in HEK293T cell line in three biological replicates. Cells were harvested 
48 hours post-transfection and mirVana miRNA Isolation Kit (Thermo Fisher Scientific) was used to isolate total 
RNA. 1 micro-gram of total RNA was treated with DNase I, RNase free (Thermo Fisher Scientific) to get rid 
of genomic DNA contamination. DNase I treated RNA was used to make cDNA using High-Capacity cDNA 
Reverse Transcription Kit (Thermo Fisher Scientific) and QuantiMir Kit (System Biosciences) following man-
ufacturer’s protocol. qRT-PCR was done to quantify the levels of Pri-, Pre- and mature mir-411. Relative fold 
change of edited miR-411 over unedited was calculated using 2−ΔΔCt method.
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